Detail Information of Exogenous Modulation

General Information of Drug Transporter (DT)
DT ID DTD0123 Transporter Info
Gene Name SLC18A1
Transporter Name Vesicular amine transporter 1
Gene ID
6570
UniProt ID
P54219
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Approved Drug

  Tretinoin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tretinoin increases the expression of SLC18A1 [1]

  Permethrin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Permethrin increases the expression of SLC18A1 [2]

  Reserpine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Reserpine inhibits the activity of SLC18A1 [3]

  Tetrabenazine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tetrabenazine inhibits the activity of SLC18A1 [4] , [5]

Drug in Preclinical Test

  (+)-JQ1

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 (+)-JQ1 inhibits the expression of SLC18A1 [6]

Drug Withdrawn

  Fenfluramine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Fenfluramine inhibits the activity of SLC18A1 [7]
References
1 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423.
2 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259.
3 Amine precursor uptake and decarboxylation: significance for processing of the rat gastrin precursor. J Physiol. 1997 Jun 1;501 ( Pt 2):363-74.
4 Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2. J Biol Chem. 1997 Jun 27;272(26):16301-7.
5 Multiple residues contribute independently to differences in ligand recognition between vesicular monoamine transporters 1 and 2. J Biol Chem. 1998 Feb 13;273(7):3943-7.
6 Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov. 2013 Mar;3(3):308-23.
7 Tubal sterility: Disturbances in haemostasis and cardiac arrest during the shirodkar manoeuvre (author's transl). Nouv Presse Med. 1978 Mar 11;7(10):827-30.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.